Pharmacovigilance & Medical Information: An Integrated Approach
Webinar date & time: May 16th 15:00 CET
Join our webinar and learn how you can achieve this integration from our real-world experience.
Are you interested in learning about the benefits of integrating Pharmacovigilance and Medical Information? Then, join us for our upcoming webinar, where we’ll discuss the advantages of combining these two critical components of drug safety.
Don’t miss out on this opportunity to expand your knowledge and stay up-to-date with the latest trends in drug safety. Register now and take your Pharmacovigilance and Medical Information management to the next level!
This webinar explores the benefits of integrated Pharmacovigilance and Medical Information. We’ll discuss how you can achieve this integration by sharing our real-world experience. Shortly? We aim to help you successfully integrate these functions and realize their positive impact on your operations and patient outcomes.
Join us to learn how integrated Pharmacovigilance and medical information can benefit your organization and ultimately improve patient care.
Register here!
Olga Asimaki - CMD, PhD.
International QPPV / Head of Global Medical Information
Olga Asimaki is a certified Medical Affairs professional with extensive experience in all aspects of Pharmacovigilance and Medical Information. Olga is a post-doctoral Neuroscientist holding an MSc from King’s College London and a PhD in Pharmacology. Before joining Biomapas, Olga was Head of Pharmacovigilance and Medical Information at AbbVie, leading and developing pharmacovigilance/medical information teams and systems. During her career, she has worked with global teams to successfully launch, implement and maintain a global medical information system and its processes.
Setting up Medical Information In Europe?
Let’s talk how we can team up to conduct them effectively and ensure smooth processes.
Other content that might interest you:
Pharmacovigilance in the MENA Region
This blog focuses on pharmacovigilance (PV) in the MENA Region; the Middle East and North Africa. We do this by comparing the MENA region and Europe...
Selecting a Pharmacovigilance Drug Safety Database
Selecting a Pharmacovigilance Drug Safety Database The WHO defines pharmacovigilance (PV) as the science and activities related to detecting,...
Q&A. How does the conflict between UA & RU impact the pharma industry?
Webinar: How does the conflict between UA & RU impact the pharma industry? Like the rest of the world, the pharmaceutical and biotech industries...
